Funded Tech Companies
XNK Therapeutics
Based in Huddinge, XNK Therapeutics raised its funding from Vinnova.
Company Overview
Company Name
XNK Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Hälsovägen 7 Novum
Huddinge, 141 57
SE
Huddinge, 141 57
SE
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
XNK Therapeutics is a clinical-stage biotechnology company developing unique and individualized natural killer (NK) cell-based cancer therapies. The R&D pipeline targets areas of high unmet medical need within both hematological malignancies and solid tumors. The most advanced product candidate, evencaleucel, is being evaluated in a phase II clinical study in combination with the CD38 monoclonal antibody isatuximab, as consolidation therapy following stem cell transplantation in newly diagnosed multiple myeloma patients.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/9/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Johan Liwing
Chief Financial Officer
Hugo Petit
Chief Medical Officer
Peter Hovstadius
Chief Scientific Officer
Anna Maltais
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs